SA
RPRX logo
Royalty Pharma plc(RPRX)
Updated 12:41 PM ETAbout this dataData status
$68.01▼-0.66 (-0.96%)

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 26.4 · elevated volatility

Overview →

Royalty Pharma plc (RPRX)

Operating Expenses

$853.22M

TTM · Period ending: · USD

RPRX logo

RPRX Operating Expenses

Latest reported$853.22M
RPRX Operating Expenses ($789.98M → $853.22M)
High-resolution chart · PNG

What is operating expenses?

Expenses from normal business operations (SG&A, R&D, etc.).

RPRX operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Royalty Pharma plc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
818,675,000
971,132,000
862,404,000
1,930,150,000
858,748,000
526,954,000
-808,922,000
430,448,000
658,238,000
1,086,333,000
789,982,000

Frequently asked questions: RPRX operating expenses

What is Royalty Pharma plc (RPRX)'s current operating expenses?

Royalty Pharma plc (RPRX)'s latest reported operating expenses (TTM) is $853.22M as of Sep 30, 2026. Expenses from normal business operations (SG&A, R&D, etc.).

How much historical operating expenses data is available for RPRX?

Stock Alarm Pro provides 11 dated annual fiscal periods observations for Royalty Pharma plc (RPRX)'s operating expenses, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare RPRX's operating expenses to peers or set an alert?

You can open RPRX's operating expenses in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on RPRX delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.